Mass ligand-binding screening strategies for identification of leads for new drug discovery.
Burch
R M
RM
Inflammation Programs and Research Technology, Nova Pharmaceutical Corporation, Baltimore, MD 21224.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008024:Ligands; D011955:Receptors, Drug / Q000737:chemistry / Q000187:drug effects*
D008024:Ligands; D011955:Receptors, Drug